| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 1,211 | 1,127 | +7.5% |
| EBITDA | 212 | 197 | +7.6% |
| EBITDA margin | 17.5% | 17.5% | 0.0 pts |
| Profit before tax | 151 | 127 | +18.7% |
| Net profit | 130 | 101 | +29.0% |
| EPS | ₹9.77 | ₹7.57 | +29.1% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 12,636 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 450 | 217 | 96.9 | 169 | 82.6 | ||
| 1,291 | 1,291 | 1,813 | 1,621 | 916 | ||
| 13,477 | — | — | — | — | ||
| 4,686 | 4,457 | 3,106 | 2,654 | 2,071 | ||
| — | +43.5% | +17.0% | +28.1% | — | ||
| 782 | 733 | 555 | 445 | 400 | ||
| 16.7% | 16.4% | 17.9% | 16.8% | 19.3% | ||
| 623 | 581 | 457 | 348 | 336 | ||
| 462 | 388 | 310 | 250 | 269 | ||
| 9.9% | 8.7% | 10.0% | 9.4% | 13.0% | ||
| ₹34.58 | ₹29.07 | ₹23.24 | ₹18.73 | ₹20.14 | ||
| — | +25.1% | +24.1% | −7.0% | — | ||
| — | 858 | 290 | 55.4 | 198 | ||
| — | −69.8 | −418 | −513 | −332 | ||
| 788 | 788 | −128 | −458 | −134 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 12,635.8 | |
| - Cash, Equiv & ST Investments | 82.6 | 169.1 | 96.9 | 216.5 | 449.6 | |
| + Total Debt | 916.1 | 1,620.8 | 1,812.6 | 1,290.7 | 1,290.7 | |
| Enterprise Value | — | — | — | — | 13,476.9 | |
| Revenue | 2,071.2 | 2,653.7 | 3,105.7 | 4,457.4 | 4,686.2 | |
| Growth %, YoY | — | +28.1 | +17.0 | +43.5 | — | |
| EBITDA | 399.9 | 445.3 | 555.1 | 732.9 | 782.4 | |
| Margin % | 19.31 | 16.78 | 17.87 | 16.44 | 16.70 | |
| EBIT | 336.1 | 347.6 | 456.6 | 581.0 | 623.5 | |
| Net Income | 268.9 | 250.1 | 310.3 | 388.1 | 461.8 | |
| Margin % | 12.98 | 9.42 | 9.99 | 8.71 | 9.85 | |
| EPS, Adj (current shares) | 20.14 | 18.73 | 23.24 | 29.07 | 34.58 | |
| Growth %, YoY | — | -7.0 | +24.1 | +25.1 | — | |
| Cash from Operations | 198.3 | 55.4 | 289.7 | 858.3 | — | |
| Capital Expenditures | -332.3 | -513.3 | -418.0 | -69.8 | — | |
| Free Cash Flow | -134.0 | -457.9 | -128.3 | 788.5 | 788.5 | |
Prices at the previous close · figures from the company's filings with NSE
CCL Products (I) (NSE: CCL) had a market capitalisation of ₹12,636 crore at the previous close (₹946.30 a share), a PE ratio of 27.4 on the last four quarters' profit and a price-to-book ratio of 4.74. In FY26 its consolidated net profit was ₹388 crore on revenue of ₹4,457 crore; in Q2 FY27 (July–September 2026) it was ₹130 crore, up 29.0% year on year. Its debt-to-equity ratio was 0.45 on 30 September 2026. Promoters held 46.16% of the shares on 30 September 2026.
CCL Products (I)'s PE ratio is 27.4 at the previous close (₹946.30 a share): a market capitalisation of ₹12,636 crore divided by consolidated net profit of ₹462 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹388 crore) it is 32.6.
CCL Products (I)'s debt-to-equity ratio was 0.45 on 30 September 2026: borrowings of ₹1,192 crore against total equity of ₹2,663 crore. A year earlier, on 30 September 2025, it was 0.76.
CCL Products (I)'s net worth — shareholders' equity in its consolidated balance sheet — was ₹2,663 crore on 30 September 2026, up 27.6% from ₹2,087 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹12,636 crore at the previous close.
CCL Products (I)'s price-to-book (PB) ratio is 4.74 at the previous close: a market capitalisation of ₹12,636 crore divided by shareholders' equity (book value) of ₹2,663 crore on 30 September 2026. That is a book value of ₹199.46 per share against a share price of ₹946.30.
In FY26, CCL Products (I)'s return on equity (ROE) was 18.0% and its return on capital employed (ROCE) was 21.3%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 17.1% and ROCE 18.8%.
CCL Products (I)'s book value per share was ₹199.46 on 30 September 2026: shareholders' equity of ₹2,663 crore divided by the 13.35 crore shares in issue, up 27.3% from ₹156.71 a year earlier. The share price at the previous close was ₹946.30.
CCL Products (I)'s market capitalisation was ₹12,636 crore at the previous close: 13.35 crore shares at ₹946.30 each.
No. CCL Products (I) had borrowings of ₹1,192 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.45. Its cash and current investments were ₹451 crore, so its net debt was ₹742 crore.
CCL Products (I)'s basic earnings per share (EPS) were ₹29.15 in FY26, against ₹23.31 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹34.67.
Promoters held 46.16% of CCL Products (I) on 30 September 2026, up 0.02 percentage points from 46.14% the previous quarter and up 0.05 percentage points from 46.11% a year earlier, according to the shareholding pattern filed with NSE.
In FY26, CCL Products (I) generated ₹858 crore of cash from operations and spent ₹69.8 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹788 crore. In FY25 it was −₹128 crore.
CCL Products (I) has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
On 30 September 2026, CCL Products (I)'s shares were held by promoters 46.16%, foreign portfolio investors (FII/FPI) 12.12%, domestic institutions (DII) 21.41% (including mutual funds at 18.89%) and retail and other non-institutional investors 20.18%. Over the year, FII holding was up 1.59 percentage points from 10.53% and DII holding was down 0.42 percentage points from 21.83%.
CCL Products (I)'s latest results are for Q2 FY27 (July–September 2026), filed on 15 October 2026: consolidated net profit ₹130 crore, up 29.0% from ₹101 crore in Q2 FY26; revenue from operations ₹1,211 crore, up 7.5% year on year.
In FY26 (April 2025–March 2026), CCL Products (I)'s consolidated net profit was ₹388 crore, up 25.1% from ₹310 crore in FY25, on revenue from operations of ₹4,457 crore (up 43.5%). Over three years, from FY23, net profit was up 44.3%.
On FY26 consolidated figures, against Tata Consumer, Bikaji Foods International and Bombay Burmah Trading Corporation: CCL Products (I)'s operating margin of 13.0% is the second highest of the four (Tata Consumer 10.7%, Bikaji Foods International 10.5%, Bombay Burmah Trading Corporation 15.8%; peer average 12.3%); its return on equity of 18.0% is the second highest of the four (Tata Consumer 7.4%, Bikaji Foods International 17.3%, Bombay Burmah Trading Corporation 19.6%; peer average 14.8%); its revenue growth over three years of 29.1% a year is the highest of the four (Tata Consumer 13.8% a year, Bikaji Foods International 15.1% a year, Bombay Burmah Trading Corporation 5.5% a year; peer average 11.4% a year).
In FY26, CCL Products (I) earned net profit of ₹388 crore on revenue of ₹4,457 crore, against ₹1,542 crore on ₹20,290 crore for Tata Consumer. CCL Products (I)'s operating margin was 13.0% (Tata Consumer 10.7%) and its return on equity 18.0% (Tata Consumer 7.4%).
From CCL Products (I)'s own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.